Prothena Corporation plc is a late-stage clinical
         biotechnology company focused on the discovery,
      development and commercialization of novel
   protein immunotherapies for the potential
  treatment of diseases that involve
amyloid or cell adhesion.

LATEST NEWS

Dale B. Schenk